1096 related articles for article (PubMed ID: 17870108)
21. Propiverine increases urethral wall catecholamine levels and bladder leak point pressure in rats.
Nishijima S; Sugaya K; Kadekawa K; Ashitomi K; Ueda T; Yamamoto H
Int J Urol; 2016 Jan; 23(1):93-9. PubMed ID: 26502799
[TBL] [Abstract][Full Text] [Related]
22. The effects of alpha-adrenoceptor antagonists on the urethral perfusion pressure of the female rat.
Bae JH; Jung PB; Lee JG
BJU Int; 2005 Nov; 96(7):1131-5. PubMed ID: 16225542
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological effects of solifenacin on human isolated urinary bladder.
Masunaga K; Yoshida M; Inadome A; Murakami S; Sugiyama Y; Satoji Y; Maeda Y; Ueda S
Pharmacology; 2008; 82(1):43-52. PubMed ID: 18434763
[TBL] [Abstract][Full Text] [Related]
24. Suppression of detrusor overactivity in rats with bladder outlet obstruction by a type 4 phosphodiesterase inhibitor.
Nishiguchi J; Kwon DD; Kaiho Y; Chancellor MB; Kumon H; Snyder PB; Yoshimura N
BJU Int; 2007 Mar; 99(3):680-6. PubMed ID: 17155980
[TBL] [Abstract][Full Text] [Related]
25. Effects of the gonadotropin-releasing hormone antagonist ganirelix on normal micturition and prostaglandin E(2)-induced detrusor overactivity in conscious female rats.
Russo A; Castiglione F; Salonia A; Benigni F; Rigatti P; Montorsi F; Andersson KE; Hedlund P
Eur Urol; 2011 May; 59(5):868-74. PubMed ID: 21196074
[TBL] [Abstract][Full Text] [Related]
26. Intravesical atropine compared to oral oxybutynin for neurogenic detrusor overactivity: a double-blind, randomized crossover trial.
Fader M; Glickman S; Haggar V; Barton R; Brooks R; Malone-Lee J
J Urol; 2007 Jan; 177(1):208-13; discussion 213. PubMed ID: 17162046
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological Properties of Propiverine Contribute to Improving Lower Urinary Tract Dysfunctions in Rats with Spinal Cord Injuries.
Sakakibara F; Takahama K; Nanri M; Sasaki E
Drug Res (Stuttg); 2016 Sep; 66(9):464-469. PubMed ID: 27750360
[TBL] [Abstract][Full Text] [Related]
28. Effect of botulinum toxin on detrusor overactivity induced by intravesical adenosine triphosphate and capsaicin in a rat model.
Atiemo H; Wynes J; Chuo J; Nipkow L; Sklar GN; Chai TC
Urology; 2005 Mar; 65(3):622-6. PubMed ID: 15780404
[TBL] [Abstract][Full Text] [Related]
29. Role of a central muscarinic cholinergic pathway for relaxation of the proximal urethra during the voiding phase in rats.
Masuda H; Tsujii T; Azuma H; Oshima H
J Urol; 2001 Mar; 165(3):999-1003. PubMed ID: 11176529
[TBL] [Abstract][Full Text] [Related]
30. Sacral neuromodulation in women with idiopathic detrusor overactivity incontinence: decreased overactivity but unchanged bladder contraction strength and urethral resistance during voiding.
Groen J; Ruud Bosch JL; van Mastrigt R
J Urol; 2006 Mar; 175(3 Pt 1):1005-9; discussion 1009. PubMed ID: 16469603
[TBL] [Abstract][Full Text] [Related]
31. [Inhibitory effect of a calcium entry blocker (verapamil) on detrusor muscle contractility: feasibility of clinical application].
Gotoh M; Kondo A; Mitsuya H
Hinyokika Kiyo; 1987 Mar; 33(3):357-63. PubMed ID: 3618404
[TBL] [Abstract][Full Text] [Related]
32. Changes in urethral function with bladder filling in the presence of urodynamic stress incontinence and detrusor overactivity.
Chaliha C; Digesu GA; Hutchings A; Khullar V
Am J Obstet Gynecol; 2005 Jan; 192(1):60-5. PubMed ID: 15672004
[TBL] [Abstract][Full Text] [Related]
33. OAB without an overactive bladder in the acute prostaglandin E2 rat model.
Hokanson JA; Langdale CL; Sridhar A; Grill WM
Am J Physiol Renal Physiol; 2017 Nov; 313(5):F1169-F1177. PubMed ID: 28768666
[TBL] [Abstract][Full Text] [Related]
34. The effect of tamsulosin on the resting tone and the contractile behaviour of the female urethra: a functional urodynamic study in healthy women.
Reitz A; Haferkamp A; Kyburz T; Knapp PA; Wefer B; Schurch B
Eur Urol; 2004 Aug; 46(2):235-40; discussion 240. PubMed ID: 15245819
[TBL] [Abstract][Full Text] [Related]
35. Propiverine vs oxybutynin for treating neurogenic detrusor overactivity in children and adolescents: results of a multicentre observational cohort study.
Madersbacher H; Mürtz G; Alloussi S; Domurath B; Henne T; Körner I; Niedeggen A; Nounla J; Pannek J; Schulte-Baukloh H; Schultz-Lampel D; Bock P; Strugala G
BJU Int; 2009 Mar; 103(6):776-81. PubMed ID: 19007380
[TBL] [Abstract][Full Text] [Related]
36. Urethral dysfunction in diabetic rats.
Torimoto K; Fraser MO; Hirao Y; De Groat WC; Chancellor MB; Yoshimura N
J Urol; 2004 May; 171(5):1959-64. PubMed ID: 15076321
[TBL] [Abstract][Full Text] [Related]
37. Alterations in purinergic and cholinergic components of contractile responses of isolated detrusor contraction in a rat model of partial bladder outlet obstruction.
Banks FC; Knight GE; Calvert RC; Morgan RJ; Burnstock G
BJU Int; 2006 Feb; 97(2):372-8. PubMed ID: 16430650
[TBL] [Abstract][Full Text] [Related]
38. Effects of solifenacin succinate (YM905) on detrusor overactivity in conscious cerebral infarcted rats.
Suzuki M; Ohtake A; Yoshino T; Yuyama H; Hayashi A; Ukai M; Okutsu H; Noguchi Y; Sato S; Sasamata M
Eur J Pharmacol; 2005 Apr; 512(1):61-6. PubMed ID: 15814091
[TBL] [Abstract][Full Text] [Related]
39. Propiverine: a review of its use in the treatment of adults and children with overactive bladder associated with idiopathic or neurogenic detrusor overactivity, and in men with lower urinary tract symptoms.
McKeage K
Clin Drug Investig; 2013 Jan; 33(1):71-91. PubMed ID: 23288694
[TBL] [Abstract][Full Text] [Related]
40. Increased urinary nerve growth factor as a predictor of persistent detrusor overactivity after bladder outlet obstruction relief in a rat model.
Lee SR; Hong CH; Choi YD; Kim JH
J Urol; 2010 Jun; 183(6):2440-4. PubMed ID: 20403616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
